Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test, End Use, and Region - Market Forecast, 2025-2034

PUBLISHED: April 1, 2025

PAGES: 125 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The Guillain-Barre syndrome (GBS) diagnostics market size is expected to reach USD 190.71 million by 2034, according to a new study by Polaris Market Research. The report "Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test (Lumber Puncture, Nerve Conduction, Electromyography, and Others), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Guillain-Barre Syndrome (GBS) diagnostics involves a combination of clinical evaluation and tests such as nerve conduction studies and lumbar puncture to confirm the presence of this rare autoimmune disorder affecting the peripheral nervous system.

Technological advancements in medical diagnostics are driving the GBS diagnostics market growth. Newer, more sophisticated tools such as high-resolution nerve conduction studies and improved lumbar punctures allow healthcare professionals to diagnose GBS more accurately and faster than before. These developments have reduced the chances of misdiagnosis, which delay treatment and worsen the patient's condition. Moreover, innovative diagnostic platforms now offer noninvasive, quicker, and more affordable options for both patients and healthcare providers, making it easier to identify and treat GBS effectively. These ongoing innovations are driving the Guillain-Barre syndrome diagnostics market expansion.

Increasing funding for medical research has significantly impacted the Guillain-Barre Syndrome diagnostics market trends. Governments, private organizations, and healthcare institutions are investing more resources into studying GBS, its causes, and improving diagnostic efficiency. These investments have led to the development of new methods, tools, and technologies that improve accuracy and reduce diagnosis time. Research funding has also deepened the understanding of the disease, leading to more effective detection strategies. Financial support for GBS research continues to drive the availability of advanced diagnostic solutions, making early detection and treatment more accessible to patients.

Guillain-Barre Syndrome Diagnostics Market Report Highlights

Based on end use, the hospital and clinics segment dominated the Guillain-Barre syndrome diagnostics market share in 2024 due to the availability of the required resources for the diagnosis of GBS.

The lumber puncture segment, by test, is expected to witness the fastest growth during the forecast period as it is a critical test that helps diagnose GBS by analyzing the cerebrospinal fluid for elevated protein levels.

In 2024, North America dominated the GBS diagnostics market revenue share, driven by advanced healthcare infrastructure and high awareness of rare diseases.

Asia Pacific is expected to record a significant share during the forecast period, due to improving healthcare infrastructure and increasing awareness of rare diseases.

A few global key market players are Alpine Biomed; Bionen Medical Devices; Cadwell Industries, Inc; Deymed Diagnostic; EMS Biomedical; Medtronic plc; Natus Medical Incorporated; Neurosoft; Nihon Kohden Corporation; and Rochester Electro-Medical, Inc.

Polaris Market Research has segmented the Guillain-Barre syndrome diagnostics market report on the basis of test, end use, and region:

By Test (Revenue - USD Million, 2020-2034)

Lumbar Puncture
Nerve Conduction
Electromyography
Other

By End Use (Revenue - USD Million, 2020-2034)

Hospitals and Clinics
Diagnostic Laboratories
Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

Product Code: PM5538

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Guillain-Barre Syndrome Diagnostics Market Insights

4.1. Guillain-Barre Syndrome Diagnostics Market - Market Snapshot
4.2. Guillain-Barre Syndrome Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Geriatric Population
  - 4.2.1.2. Rising Prevalence of Guillain-Barre Syndrome
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of Skilled Workforce
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Guillain-Barre Syndrome Diagnostics Market End Use Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Guillain-Barre Syndrome Diagnostics Market, by Test

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
5.3. Lumbar Puncture
- 5.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Lumbar Puncture, by Region, 2020-2034 (USD Million)
5.4. Nerve Conduction
- 5.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Nerve Conduction, by Region, 2020-2034 (USD Million)
5.5. Electromyography
- 5.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Electromyography, by Region, 2020-2034 (USD Million)
5.6. Other
- 5.6.1. Global Guillain-Barre Syndrome Diagnostics Market, by Other, by Region, 2020-2034 (USD Million)

6. Global Guillain-Barre Syndrome Diagnostics Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
6.3. Hospitals and Clinics
- 6.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Million)
6.4. Diagnostic Laboratories
- 6.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
6.5. Others
- 6.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Guillain-Barre Syndrome Diagnostics Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Guillain-Barre Syndrome Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
7.3. Guillain-Barre Syndrome Diagnostics Market - North America
- 7.3.1. North America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.3.2. North America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.3.3. Guillain-Barre Syndrome Diagnostics Market - U.S.
  - 7.3.3.1. U.S.: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.3.3.2. U.S.: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.3.4. Guillain-Barre Syndrome Diagnostics Market - Canada
  - 7.3.4.1. Canada: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.3.4.2. Canada: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
7.4. Guillain-Barre Syndrome Diagnostics Market - Europe
- 7.4.1. Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.4.2. Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.3. Guillain-Barre Syndrome Diagnostics Market - UK
  - 7.4.3.1. UK: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.3.2. UK: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.4. Guillain-Barre Syndrome Diagnostics Market - France
  - 7.4.4.1. France: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.4.2. France: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.5. Guillain-Barre Syndrome Diagnostics Market - Germany
  - 7.4.5.1. Germany: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.5.2. Germany: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.6. Guillain-Barre Syndrome Diagnostics Market - Italy
  - 7.4.6.1. Italy: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.6.2. Italy: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.7. Guillain-Barre Syndrome Diagnostics Market - Spain
  - 7.4.7.1. Spain: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.7.2. Spain: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.8. Guillain-Barre Syndrome Diagnostics Market - Netherlands
  - 7.4.8.1. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.8.2. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.9. Guillain-Barre Syndrome Diagnostics Market - Russia
  - 7.4.9.1. Russia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.9.2. Russia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.4.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.4.10.2. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
7.5. Guillain-Barre Syndrome Diagnostics Market - Asia Pacific
- 7.5.1. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.3. Guillain-Barre Syndrome Diagnostics Market - China
  - 7.5.3.1. China: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.3.2. China: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.4. Guillain-Barre Syndrome Diagnostics Market - India
  - 7.5.4.1. India: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.4.2. India: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.5. Guillain-Barre Syndrome Diagnostics Market - Malaysia
  - 7.5.5.1. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.5.2. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.6. Guillain-Barre Syndrome Diagnostics Market - Japan
  - 7.5.6.1. Japan: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.6.2. Japan: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.7. Guillain-Barre Syndrome Diagnostics Market - Indonesia
  - 7.5.7.1. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.7.2. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.8. Guillain-Barre Syndrome Diagnostics Market - South Korea
  - 7.5.8.1. South Korea: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.8.2. South Korea: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.9. Guillain-Barre Syndrome Diagnostics Market - Australia
  - 7.5.9.1. Australia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.9.2. Australia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.5.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.5.10.2. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
7.6. Guillain-Barre Syndrome Diagnostics Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.3. Guillain-Barre Syndrome Diagnostics Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.3.2. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.4. Guillain-Barre Syndrome Diagnostics Market - UAE
  - 7.6.4.1. UAE: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.4.2. UAE: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.5. Guillain-Barre Syndrome Diagnostics Market - Israel
  - 7.6.5.1. Israel: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.5.2. Israel: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.6. Guillain-Barre Syndrome Diagnostics Market - South Africa
  - 7.6.6.1. South Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.6.2. South Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.6.7. Guillain-Barre Syndrome Diagnostics Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.6.7.2. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
7.7. Guillain-Barre Syndrome Diagnostics Market - Latin America
- 7.7.1. Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
- 7.7.2. Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.7.3. Guillain-Barre Syndrome Diagnostics Market - Mexico
  - 7.7.3.1. Mexico: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.7.3.2. Mexico: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.7.4. Guillain-Barre Syndrome Diagnostics Market - Brazil
  - 7.7.4.1. Brazil: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.7.4.2. Brazil: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.7.5. Guillain-Barre Syndrome Diagnostics Market - Argentina
  - 7.7.5.1. Argentina: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.7.5.2. Argentina: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 7.7.6. Guillain-Barre Syndrome Diagnostics Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  - 7.7.6.2. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Alpine Biomed
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Bionen Medical Devices
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Cadwell Industries, Inc
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Deymed Diagnostic
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. EMS Biomedical
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Medtronic plc
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Natus Medical Incorporated
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Neurosoft
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Nihon Kohden Corporation
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Rochester Electro-Medical, Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development

Product Code: PM5538

List of Tables:

Table 1 Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 2 Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 3 North America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 4 North America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 5 U.S.: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 6 U.S.: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 7 Canada: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 8 Canada: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 9 Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 10 Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 11 UK: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 12 UK: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 13 France: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 14 France: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 15 Germany: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 16 Germany: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 17 Italy: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 18 Italy: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 19 Spain: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 20 Spain: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 21 Netherlands: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 22 Netherlands: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 23 Russia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 24 Russia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 25 Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 26 Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 27 Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 28 Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 29 China: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 30 China: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 31 India: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 32 India: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 33 Malaysia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 34 Malaysia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 35 Japan: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 36 Japan: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 37 Indonesia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 38 Indonesia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 39 South Korea: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 40 South Korea: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 41 Australia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 42 Australia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 43 Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 44 Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 45 Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 46 Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 47 Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 48 Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 49 UAE: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 50 UAE: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 51 Israel: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 52 Israel: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 53 South Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 54 South Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 55 Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 56 Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 57 Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 58 Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 59 Mexico: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 60 Mexico: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 61 Brazil: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 62 Brazil: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 63 Argentina: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 64 Argentina: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
Table 65 Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
Table 66 Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)

List of Figures:

Figure 1. Global Guillain-Barre Syndrome Diagnostics Market, 2020-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Test
Figure 7. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2024 & 2034 (USD Million)
Figure 8. Market by End Use
Figure 9. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2024 & 2034 (USD Million)